ERBB2 and neoplasm: The radiolabeled antibody concentration in the blood decreased and the MDA-MB-231 tumor is HER2-negative tumor, which does not have HER2 target protein, 89Zr-DFO-pertuzumab could not be bound and internalized in the MDA-MB-231 tumor and tumor uptake maintained at all time points.